Lactobacillus plantarum 299v: Benefits, Uses, and Safety

Lactobacillus plantarum 299v (often abbreviated LP299v) is one of the most thoroughly studied probiotic strains, with roughly three decades of clinical and laboratory research behind it.¹ Its best-supported benefits center on reducing abdominal pain and bloating in irritable bowel syndrome and improving iron absorption from food and supplements. The strain also shows promise for cardiovascular inflammation, gut barrier support, and preserving healthy gut fermentation during antibiotic treatment, though the strength of evidence varies across these areas.

A Quick Note on the Name

If you see this strain referred to as Lactiplantibacillus plantarum 299v instead of Lactobacillus plantarum 299v, it is the same organism. A 2020 reclassification reorganized the sprawling Lactobacillus genus, and what was previously Lactobacillus plantarum is now formally Lactiplantibacillus plantarum.¹ Supplement labels, older papers, and newer papers use both names interchangeably. The strain number 299v, and the DSM catalog number 9843, are the identifiers that tell you it is the specific strain the clinical trials were done on.

How It Survives and Sticks in Your Gut

One thing that sets LP299v apart from many probiotic strains is its ability to actually reach the intestine alive and latch on to the gut lining. Lactobacillus plantarum as a species tends to tolerate bile well, surviving concentrations well above what the human gut normally contains. That bile tolerance is a basic prerequisite for any probiotic to do much once swallowed.

What makes 299v particularly interesting is its adhesion mechanism. The strain produces a surface protein called Msa that binds to mannose, a sugar found on the surface of human intestinal cells. In lab comparisons, LP299v showed stronger mannose-specific adhesion than another well-known L. plantarum strain (WCFS1), suggesting it is especially good at attaching to the gut lining.² Earlier work confirmed this mannose-binding adhesion in LP299v using human colon cells in the lab, and the researchers proposed that this adhesin could help the strain colonize the intestine.³ This matters because a probiotic that just passes through you is less likely to influence your gut environment than one that hangs around and interacts with the tissue.

IBS Symptom Relief

The strongest clinical evidence for LP299v is in irritable bowel syndrome. Multiple randomized, placebo-controlled trials have tested it in people who meet the standard diagnostic criteria for IBS, and the results have been consistent enough to make this one of the strain’s headline uses.

In a four-week trial of IBS patients, those taking LP299v had lower abdominal pain severity and fewer daily pain episodes than the placebo group. Bloating improved as well. By the end of the trial, about 78% of participants rated the probiotic’s effect as excellent or good, compared to only about 8% in the placebo group.⁴ An earlier controlled trial found even more striking results: all patients taking LP299v reported resolution of abdominal pain, compared to about half in the placebo group. Across all IBS symptoms combined, improvement was noted in 95% of the probiotic group versus 15% on placebo.⁵

For people specifically dealing with diarrhea-predominant IBS, a dose-response trial found that a higher dose (10 billion CFU) produced more stool-consistency responders than a lower dose (1 billion CFU), and both outperformed placebo. By day 56, about 88% of participants in the higher-dose group met the criteria for improved stool consistency, compared to roughly 63% in the lower-dose group and about 26% on placebo.⁶ That dose-response pattern is useful because it suggests the effect is real and not just placebo, and it gives a practical steer toward higher-count products if you are shopping for a supplement.

Enhancing Iron Absorption

This is one of the more unusual benefits in the probiotic world. Several studies in women of reproductive age have found that LP299v meaningfully increases how much iron you absorb from food or supplements.

In double-isotope studies of menstruating women (a method that precisely tracks iron uptake), adding freeze-dried LP299v to iron capsules increased absorption by a statistically significant margin, on the order of 3 to 5 percentage points above baseline absorption levels of about 17 to 21%.⁷ In another crossover trial, a fruit drink containing LP299v increased iron absorption by roughly 50% compared to the same drink without the probiotic, with mean absorption jumping from about 19% to about 29%.⁸

A 12-week trial in iron-deficient female athletes painted a slightly more nuanced picture. Women taking LP299v alongside iron supplements saw a 70% increase in plasma ferritin (the storage form of iron), compared to 42% in women taking iron alone. However, that between-group difference did not reach statistical significance, partly because both groups were improving.⁹ The trend was in the right direction, and the earlier acute-absorption studies provide a plausible reason to expect a cumulative benefit over time, but the long-term ferritin data is not yet conclusive.

How the Iron-Boosting Mechanism Works

The iron story gets more interesting once you look at the proposed mechanism. Iron in food and supplements exists in two main forms, and the form that is harder for your body to absorb (ferric iron, or Fe3+) needs to be converted into a more absorbable form (ferrous iron, Fe2+) before your intestinal cells can take it up. Your gut lining does this conversion using an enzyme called DCYTB.

In cell-culture experiments, adding LP299v increased the amount of ferric iron available and upregulated the DCYTB enzyme in intestinal cells.¹⁰ In plain terms, the probiotic appears to help your gut cells gear up for iron absorption. This is relevant for anyone prone to iron deficiency, particularly menstruating women, athletes, and people on plant-heavy diets where iron comes mostly in the harder-to-absorb ferric form.

Cardiovascular and Anti-Inflammatory Effects

A separate line of research has explored LP299v in people with stable coronary artery disease. In a trial of men with established heart disease, six weeks of LP299v supplementation improved blood vessel function, measured by how well the brachial artery dilated in response to increased blood flow. The probiotic also lowered circulating levels of several inflammatory markers, including IL-8, IL-12, and leptin.¹¹ A follow-up analysis of gene expression in these participants found broad downregulation of inflammatory signaling pathways and an increase in regulatory T-cell activity, suggesting the probiotic’s effects were not superficial but reflected real shifts in immune behavior.¹²

An earlier study in smokers also found that LP299v reduced systolic blood pressure, leptin, and fibrinogen, along with drops in markers of oxidative stress and the inflammatory cytokine IL-6. Immune cells (monocytes) from treated participants were less likely to stick to blood vessel cells in the lab, which is a step in the process that leads to atherosclerosis.¹³

These are intriguing findings, but they come from relatively small studies and mostly in men with existing cardiovascular risk. Whether LP299v would meaningfully shift cardiovascular outcomes in healthy people, or in women, remains untested. Think of this as a promising early signal rather than a proven heart-health intervention.

Protecting Gut Fermentation During Antibiotic Use

Antibiotics are notorious for disrupting the gut’s microbial ecosystem, and one measurable consequence is a drop in short-chain fatty acids, the beneficial compounds your gut bacteria produce when they ferment dietary fiber. LP299v appears to buffer against this disruption.

In patients with recurrent C. difficile-associated diarrhea who were taking metronidazole, those also receiving LP299v maintained higher levels of fecal short-chain fatty acids than the placebo group. Butyrate, a short-chain fatty acid especially important for colon health, dropped significantly in the placebo group but stayed relatively stable in those taking the probiotic.¹⁴ Separately, healthy volunteers consuming LP299v in a fermented rosehip drink showed increases in total fecal short-chain fatty acids and acetic and propionic acid over three weeks.¹⁵

When it comes to preventing the actual gastrointestinal side effects of antibiotics, the picture is more mixed. A large study in adults found that taking LP299v alongside antibiotics reduced the odds of developing loose or watery stools by about 31% and cut the odds of nausea roughly in half.¹⁶ However, a randomized trial in children taking antibiotics found that LP299v was no better than placebo at preventing loose stools or abdominal symptoms, though it was well tolerated.¹⁷ So the antibiotic-support benefit seems more reliable in adults than in children, at least based on current evidence.

Strengthening the Gut Barrier

Your intestinal lining is held together by tight junction proteins that act as a seal between cells, controlling what passes from the gut into your bloodstream. When those junctions loosen, the result is increased intestinal permeability, sometimes called “leaky gut.” Research on L. plantarum (including but not limited to the 299v strain) suggests these bacteria can reinforce that seal.

In a human study, L. plantarum administration increased key tight junction proteins, specifically ZO-1 and occludin, in the area around the junctions. When intestinal cells in the lab were pretreated with L. plantarum before exposure to a permeability-disrupting agent, the probiotic significantly protected against the dislocation of those same proteins and the resulting increase in permeability.¹⁸ In cell-culture work, fractions of LP299v bacteria (including heat-killed components and extracted proteins) activated the anti-inflammatory cytokine IL-10 and modulated inflammatory responses triggered by bacterial toxins, effectively protecting intestinal cells from inflammation-driven damage.¹⁹

Animal research adds another layer. In rats receiving abdominal radiation followed by colon surgery, LP299v improved wound healing (higher collagen content at the surgical site) and reduced markers of inflammation compared to controls.²⁰ These results suggest the strain’s barrier-protective and anti-inflammatory effects extend beyond a simple probiotic “coating” of the gut wall.

Safety Profile

LP299v has a strong safety track record. It has been used commercially in fermented products and supplements for decades, and clinical trials across various patient populations, including people on broad-spectrum antibiotics, children, and patients with coronary artery disease, have not raised significant safety concerns. The pediatric antibiotic trial mentioned above specifically reported that the probiotic was safe and well tolerated even though it did not outperform placebo for symptom prevention.¹⁷

One concern people sometimes raise about probiotics taken alongside antibiotics is whether the probiotic bacterium could pick up antibiotic resistance genes in the gut. Researchers tested LP299v isolates recovered from critically ill patients who were receiving both the probiotic and broad-spectrum antibiotics. The antibiotic susceptibility of LP299v remained stable after passing through these patients’ guts, meaning the strain did not acquire new resistance during transit.²¹ That is reassuring, though as always, immunocompromised individuals or those with central venous catheters should talk to their doctor before starting any probiotic.

Where the Evidence Fell Short

Not every hoped-for application of LP299v has panned out in trials. Some of the more disappointing results have come from surgical settings, where researchers hoped the probiotic could reduce bacterial translocation (bacteria crossing from the gut into the bloodstream or lymph nodes) and postoperative infections.

In a randomized trial of elective surgical patients, LP299v showed no significant difference from placebo in rates of bacterial translocation, stomach colonization by harmful bacteria, or postoperative septic complications.²² Another trial in patients undergoing colon resection produced similar null results, finding no differences in bacterial translocation or postoperative complications between the LP299v and placebo groups.²³

These results are worth knowing because they illustrate that probiotic benefits are context-dependent. A strain that reliably improves IBS symptoms and iron absorption in otherwise healthy people does not automatically translate into benefits in high-acuity surgical situations where the gut is under fundamentally different stresses. It is a reminder that “probiotic” is not a magic category. Individual strains have specific, evidence-backed niches, and LP299v’s niche is primarily functional digestive health and nutrient absorption rather than acute surgical or critical care support.

Practical Considerations for Choosing a Product

Because probiotic benefits are strain-specific, the label on the product matters. You want to see “Lactobacillus plantarum 299v,” “LP299v,” or the DSM catalog number 9843. A supplement labeled simply “Lactobacillus plantarum” without a strain designation could contain an entirely different strain with none of the same clinical evidence.

Dose also matters. The IBS trials generally used doses in the range of 10 billion CFU per day, and the diarrhea-predominant IBS dose-response study found that 10 billion CFU outperformed 1 billion CFU.⁶ For iron absorption, benefits were observed with around 10 billion CFU as well.⁷ If you are picking a product primarily for IBS or iron support, aiming for at least 10 billion CFU of the specific strain is a reasonable starting point based on the available trials.

Timing relative to meals is less well established for LP299v specifically. Some products recommend taking it with food, which aligns with the general logic that food buffers stomach acid and may help more bacteria survive the journey to the intestine. Given the strain’s demonstrated bile tolerance, it is probably fairly resilient either way, but following the manufacturer’s directions is sensible until better data exists on timing.